A novel miRNA inhibits metastasis of prostate cancer via decreasing CREBBP-mediated histone acetylation
Author:
Funder
National Natural Science Foundation of China
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine
Link
http://link.springer.com/content/pdf/10.1007/s00432-020-03455-9.pdf
Reference32 articles.
1. Bang YJ et al (1994) Terminal neuroendocrine differentiation of human prostate carcinoma cells in response to increased intracellular cyclic AMP. Proc Natl Acad Sci USA 91:5330–5334. https://doi.org/10.1073/pnas.91.12.5330
2. Bhagirath D et al (2018) microRNA-1246 is an exosomal biomarker for aggressive prostate cancer. Cancer Res 78:1833–1844. https://doi.org/10.1158/0008-5472.CAN-17-2069
3. Cerami E et al (2012) The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov 2:401–404. https://doi.org/10.1158/2159-8290.CD-12-0095
4. Chen W et al (2016) Cancer statistics in China 2015. CA Cancer J Clin 66:115–132. https://doi.org/10.3322/caac.21338
5. Das C et al (2014) Binding of the histone chaperone ASF1 to the CBP bromodomain promotes histone acetylation. Proc Natl Acad Sci USA 111:E1072-1081. https://doi.org/10.1073/pnas.1319122111
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Emerging Role of Epigenetic Modifiers in Breast Cancer Pathogenesis and Therapeutic Response;Cancers;2023-08-07
2. Bioinformatics analysis reveals the potential target of rosiglitazone as an antiangiogenic agent for breast cancer therapy;BMC Genomic Data;2022-09-16
3. Histone Modifications and Non-Coding RNAs: Mutual Epigenetic Regulation and Role in Pathogenesis;International Journal of Molecular Sciences;2022-05-22
4. Regulation of epithelial-mesenchymal transition by protein lysine acetylation;Cell Communication and Signaling;2022-04-28
5. Lysine Acetylation, Cancer Hallmarks and Emerging Onco-Therapeutic Opportunities;Cancers;2022-01-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3